Back to Search
Start Over
Meningococcal vaccines in China
- Source :
- Hum Vaccin Immunother
- Publication Year :
- 2021
- Publisher :
- Informa UK Limited, 2021.
-
Abstract
- Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines. The disease incidence was markedly reduced after meningococcal vaccination was introduced in the 1980s. Currently, there are polysaccharide, conjugate, and combined vaccine formulations against meningococcal meningitis in the Chinese market, almost all of which are produced by domestic manufacturers. It is necessary to further enhance national meningococcal surveillance to improve the level of prevention and control of meningococcus. However, the immune efficacy and persistence of immunity of vaccines should be monitored. More importantly, additional investments should be made to develop serogroup B meningococcal vaccines.
- Subjects :
- China
030231 tropical medicine
Immunology
Meningococcal Vaccines
Review
Meningococcal vaccine
Meningitis, Meningococcal
Neisseria meningitidis
medicine.disease_cause
03 medical and health sciences
0302 clinical medicine
Immune system
Immunity
Humans
Immunology and Allergy
Medicine
030212 general & internal medicine
Pharmacology
Vaccines, Conjugate
business.industry
medicine.disease
Virology
Meningococcal Infections
Vaccination
Infectious disease (medical specialty)
High incidence
business
Meningitis
Subjects
Details
- ISSN :
- 2164554X and 21645515
- Volume :
- 17
- Database :
- OpenAIRE
- Journal :
- Human Vaccines & Immunotherapeutics
- Accession number :
- edsair.doi.dedup.....6ad91727c344875434ef868bf16e8b9f